Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2016 and Provides Conference Call Information
15 juin 2016 16h19 HE
|
Elite Pharmaceuticals, Inc.
Revenues Increased 150% Conference Call Scheduled for Monday, June 20 at 11:00 AM EDT NORTHVALE, N.J., June 15, 2016 ...
Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting
09 mai 2016 07h30 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today it will present data for SequestOx™ (ELI-200) at the American...
Elite Pharmaceuticals Announces Changes to their Board of Directors
12 avr. 2016 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 12, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Eugene Pfeifer to...
Elite Announces U.S. FDA Priority Review Designation for SequestOx™ NDA
17 mars 2016 07h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced that the New Drug Application (NDA) for SequestOXTM...
Elite Pharmaceuticals, Inc. Reports Strong Growth for Third Quarter of Fiscal Year 2016
09 févr. 2016 16h31 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended December 31, 2015, the third quarter...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016
05 févr. 2016 12h42 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016
09 nov. 2015 16h37 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended September 30, 2015, the second...
Elite Pharmaceuticals Announces Positive Top-Line Results From a Pivotal Phase 3 Study for Abuse-Deterrent Opioid ELI-200
21 oct. 2015 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced positive top-line results from the Phase 3 pivotal trial of...
Elite Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
02 sept. 2015 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCQB:ELTP) a specialty pharmaceutical company which manufactures and sells niche generic products and is developing a...
Elite Pharmaceuticals, Inc. Reports Record Revenues for First Quarter of Fiscal Year 2016
10 août 2015 16h19 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), announced results for the quarter ended June 30, 2015, the first quarter of its...